DexTech Medicals Reports Positive Preliminary Myeloma Study Results
DexTech Medicals says the clinical study report is complete and preliminary results are very positive.
Related stories
General Mining reports Q3 profit of 13,869 dinars
M impact | EQUITY | Oct 29, 2026, 02:49 PM UTC
Grupo Aeroportuario del Pacifico Announces Dividend of R$ 0.3601412040 per Unit
M impact | EQUITY | Oct 29, 2026, 02:49 PM UTC
PVH Announces R$ 0.067727273 per BDR Dividend
PVH announced a fourth-quarter 2026 dividend of R$ 0.067727273 per BDR.
M impact | EQUITY | Oct 29, 2026, 02:49 PM UTC
Proto Labs Reports Quarterly Results Through September 30
M impact | EQUITY | Oct 29, 2026, 02:49 PM UTC
Middle East Insurance reports Q3 insurance revenue of 14.1 million dinars
M impact | EQUITY | Oct 29, 2026, 02:47 PM UTC
Middle East Insurance Reports Q3 After-Tax Profit of 181,389 Dinars
M impact | EQUITY | Oct 29, 2026, 02:47 PM UTC